193 related articles for article (PubMed ID: 9628456)
1. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.
Kolb SA; Lahrtz F; Paul R; Leppert D; Nadal D; Pfister HW; Fontana A
J Neuroimmunol; 1998 Apr; 84(2):143-50. PubMed ID: 9628456
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with echovirus type 30 and mumps meningitis.
Sulik A; Wojtkowska M; Oldak E
Scand J Immunol; 2008 Sep; 68(3):323-7. PubMed ID: 18565120
[TBL] [Abstract][Full Text] [Related]
4. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
Matsuura E; Umehara F; Hashiguchi T; Fujimoto N; Okada Y; Osame M
J Neurol Sci; 2000 Feb; 173(1):45-52. PubMed ID: 10675579
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
6. Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion.
Azeh I; Mäder M; Smirnov A; Beuche W; Nau R; Weber F
Neurosci Lett; 1998 Nov; 256(3):127-30. PubMed ID: 9855356
[TBL] [Abstract][Full Text] [Related]
7. Effects of purulent meningitis on the changes of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase inhibitor-1 (TIMP-1) in cerebrospinal fluid of neonates.
Cui W; Luo X; Zhang Y
Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2437-2441. PubMed ID: 31894031
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis.
Sulik A; Chyczewski L
Folia Histochem Cytobiol; 2008; 46(4):437-42. PubMed ID: 19141395
[TBL] [Abstract][Full Text] [Related]
9. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Leppert D; Leib SL; Grygar C; Miller KM; Schaad UB; Holländer GA
Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
[TBL] [Abstract][Full Text] [Related]
11. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.
Lindberg RL; Sorsa T; Tervahartiala T; Hoffmann F; Mellanen L; Kappos L; Schaad UB; Leib SL; Leppert D
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):304-17. PubMed ID: 16640649
[TBL] [Abstract][Full Text] [Related]
12. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.
Umehara F; Okada Y; Fujimoto N; Abe M; Izumo S; Osame M
J Neuropathol Exp Neurol; 1998 Sep; 57(9):839-49. PubMed ID: 9737547
[TBL] [Abstract][Full Text] [Related]
14. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury.
Rosenberg GA; Dencoff JE; Correa N; Reiners M; Ford CC
Neurology; 1996 Jun; 46(6):1626-32. PubMed ID: 8649561
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia.
Conant K; McArthur JC; Griffin DE; Sjulson L; Wahl LM; Irani DN
Ann Neurol; 1999 Sep; 46(3):391-8. PubMed ID: 10482270
[TBL] [Abstract][Full Text] [Related]
16. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.
Price NM; Farrar J; Tran TT; Nguyen TH; Tran TH; Friedland JS
J Immunol; 2001 Mar; 166(6):4223-30. PubMed ID: 11238675
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.
Leppert D; Ford J; Stabler G; Grygar C; Lienert C; Huber S; Miller KM; Hauser SL; Kappos L
Brain; 1998 Dec; 121 ( Pt 12)():2327-34. PubMed ID: 9874483
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and their inhibitors.
Kugler A
Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
[TBL] [Abstract][Full Text] [Related]
19. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
